Burcu Berberoğlu Ateş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Burcu Berberoğlu Ateş has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Arzu Meltem Demir
Department of Pediatric Gastroenterology Ankara University Faculty of Medicine Ankara Turkey
3 shared publications - Gülin Hızal
Turkish Republ Hlth Minist Ankara Child Hlth Dis, Haematol Oncol Training & Res Hosp, Clin Pediat Gastroenterol Hepatol & Nutr, Ankara, Turkey
3 shared publications - Ayse Selcen Oguz Erdogan
Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
2 shared publications - Aytaç Yaman
Department of Pediatric Gastroenterology, Ministry of Health, Ankara City Hospital, Ankara, Turkey
2 shared publications - Ceyda Tuna Kırsaçlıoğlu
Department of Pediatric Gastroenterology Ankara University Faculty of Medicine Ankara Turkey
2 shared publications - Esra Karakus
Department of Pathology, Turkish Ministry of Health, Ankara Bilkent City Hospital, Ankara, Turkey
2 shared publications
Latest Publications
- Open Access
- 30 May 2022
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 16 (3) , 174-178
Assessment of Fecal Viral Shedding Among Children Who Have COVID-19 by Polymerase Chain Reaction
Objective: This study aimed to assess fecal viral shedding in children who have been confirmed COVID-19 by real time polymerase chain reaction (RT-PCR). Material and Methods: We enrolled fifty inpatient children who have been confirmed COVID-19 during first wave of outbreak in our region. All of the patients have been twice confirmed by RT-PCR within nasopharyngeal swabs. Each case was evaluated with clinical data, laboratory tests and rectal swabs. The rectal swabs were obtained five days after nasopharyngeal positivity. The clinical data was recorded within two basic categories, including common symptoms or digestive symptoms. Detection of SARS-CoV-2 in rectal swabs was performed by RT-PCR method. Results: Fifteen patients (30%) had digestive symptoms. On the 5th day, 50 rectal swabs were studied with PCR-RT. Only one of them was positive (2%). The only patient who was positive for SARS-CoV-2 on rectal swab was a symptomatic threeand-a-half-year-old girl. The patient, who became asymptomatic in the follow-up, was retested with a nasopharyngeal swab one week later, the result was negative and she was discharged on the 10th day. The second rectal smear of the patient was negative. Conclusion: We found very low rate (2%) fecal viral shedding with rectal swab PCR among children who have been confirmed COVID-19 by nasopharyngeal swab PCR. We thought that this result was due to the mild clinical course of the patients who has been diagnosed with COVID-19 we followed up. However, fecal oral transmission might still matter in children.
- 30 May 2022
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 16 (3) , 174-178
Open AccessAssessment of Fecal Viral Shedding Among Children Who Have COVID-19 by Polymerase Chain Reaction
Objective: This study aimed to assess fecal viral shedding in children who have been confirmed COVID-19 by real time polymerase chain reaction (RT-PCR). Material and Methods: We enrolled fifty inpatient children who have been confirmed COVID-19 during first wave of outbreak in our region. All of the patients have been twice confirmed by RT-PCR within nasopharyngeal swabs. Each case was evaluated with clinical data, laboratory tests and rectal swabs. The rectal swabs were obtained five days after nasopharyngeal positivity. The clinical data was recorded within two basic categories, including common symptoms or digestive symptoms. Detection of SARS-CoV-2 in rectal swabs was performed by RT-PCR method. Results: Fifteen patients (30%) had digestive symptoms. On the 5th day, 50 rectal swabs were studied with PCR-RT. Only one of them was positive (2%). The only patient who was positive for SARS-CoV-2 on rectal swab was a symptomatic threeand-a-half-year-old girl. The patient, who became asymptomatic in the follow-up, was retested with a nasopharyngeal swab one week later, the result was negative and she was discharged on the 10th day. The second rectal smear of the patient was negative. Conclusion: We found very low rate (2%) fecal viral shedding with rectal swab PCR among children who have been confirmed COVID-19 by nasopharyngeal swab PCR. We thought that this result was due to the mild clinical course of the patients who has been diagnosed with COVID-19 we followed up. However, fecal oral transmission might still matter in children.
- Open Access
- 29 September 2020
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 14 (5) , 385-390
KOLESTAZLI ÇOCUKLARDA KLİNİK VE LABORATUAR BULGULARININ YAŞ GRUPLARINA GÖRE DEĞERLENDİRİLMESİ
Objective: Cholestasis in childhood results from different etiologies according to age groups. The differences between clinical and laboratory findings in patients with cholestasis during the first 3 months of age and after 3 months are unknown. The aim of this study is to investigate the clinical, laboratory; and histopathological findings of patients with cholestasis according to age groups. Material and Methods: Between January 2013-March 2017, files of the patients diagnosed as cholestasis in 0-18 year of age were retrospectively reviewed. Demographic data, complaints, physical examination, laboratory, ultrasonography and if liver biopsy is done histopathologic findings of the patients were recorded. Results: Forty-four patients (29 M, 65%) were diagnosed as cholestasis during the study period. Twenty-five (56%) of the patients were younger than 3 months (Group 1), 19 (44%) of the patients were older than 3 months (Group 2). The patients were diagnosed as cholestasis in the first 3 months were idiopathic neonatal hepatitis (n=5, 20%), non-syndromic paucity of intrahepatic bile ducts (n=5, 20%), biliary atresia (n=3, 12%), progressive familial intrahepatic cholestasis (n=3, 12%), cholestasis owing to prematurity/ sepsis/ parenteral nutrition (n=3, 12%) respectively. Aetiology of the cholestasis after 3 months were cryptogenic hepatitis (n=5, 26.3%) and autoimmune hepatitis (n=4, 21%) respectively. Mean duration of follow up was 17.7±15.1 months. Total and direct bilirubin levels were higher in Group 1 patients (p=0.017 and p= 0.023 respectively) whereas albumin levels were lower (p=0.051). Ultrasonographic evaluation revealed statistically homogenic liver parenchyma in Group 1 (p=0.000). Liver histopathologic examination showed fibrosis in Group 2 (p=0.000). Conclusion: Cholestasis in childhood occurs different reasons. Although bilirubin levels were higher in young children, chronic changes such as liver fibrosis are common in older children.
- 29 September 2020
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 14 (5) , 385-390
Open AccessKOLESTAZLI ÇOCUKLARDA KLİNİK VE LABORATUAR BULGULARININ YAŞ GRUPLARINA GÖRE DEĞERLENDİRİLMESİ
Objective: Cholestasis in childhood results from different etiologies according to age groups. The differences between clinical and laboratory findings in patients with cholestasis during the first 3 months of age and after 3 months are unknown. The aim of this study is to investigate the clinical, laboratory; and histopathological findings of patients with cholestasis according to age groups. Material and Methods: Between January 2013-March 2017, files of the patients diagnosed as cholestasis in 0-18 year of age were retrospectively reviewed. Demographic data, complaints, physical examination, laboratory, ultrasonography and if liver biopsy is done histopathologic findings of the patients were recorded. Results: Forty-four patients (29 M, 65%) were diagnosed as cholestasis during the study period. Twenty-five (56%) of the patients were younger than 3 months (Group 1), 19 (44%) of the patients were older than 3 months (Group 2). The patients were diagnosed as cholestasis in the first 3 months were idiopathic neonatal hepatitis (n=5, 20%), non-syndromic paucity of intrahepatic bile ducts (n=5, 20%), biliary atresia (n=3, 12%), progressive familial intrahepatic cholestasis (n=3, 12%), cholestasis owing to prematurity/ sepsis/ parenteral nutrition (n=3, 12%) respectively. Aetiology of the cholestasis after 3 months were cryptogenic hepatitis (n=5, 26.3%) and autoimmune hepatitis (n=4, 21%) respectively. Mean duration of follow up was 17.7±15.1 months. Total and direct bilirubin levels were higher in Group 1 patients (p=0.017 and p= 0.023 respectively) whereas albumin levels were lower (p=0.051). Ultrasonographic evaluation revealed statistically homogenic liver parenchyma in Group 1 (p=0.000). Liver histopathologic examination showed fibrosis in Group 2 (p=0.000). Conclusion: Cholestasis in childhood occurs different reasons. Although bilirubin levels were higher in young children, chronic changes such as liver fibrosis are common in older children.
- Open Access
- 26 June 2020
- Published by Wiley in Helicobacter
- Vol. 25 (5) , e12716
Autoimmune atrophic gastritis: The role of Helicobacter pylori infection in children
Background: Autoimmune atrophic gastritis (AIG) is very rare in children. Despite a better understanding of histopathologic changes and serological markers in this disease, underlying etiopathogenic mechanisms and the effect of Helicobacter pylori (H pylori) infection are not well known. We aimed to investigate the relation between AIG and H pylori infection in children.Materials and Methods: We evaluated the presence of AIG and H pylori infection in fifty‐three patients with positive antiparietal cell antibody (APCA). Demographic data, clinical symptoms, laboratory and endoscopic findings, histopathology, and presence of H pylori were recorded.Results: The children were aged between 5 and 18 years, and 28 (52.8%) of them were male. Mean age was 14.7 ± 2.6 years (median: 15.3; min‐max: 5.2‐18), and 10 (18.8%) of them had AIG confirmed by histopathology. In the AIG group, the duration of vitamin B12 deficiency was longer (P = .022), hemoglobin levels were lower (P = .018), and APCA (P = .039) and gastrin (P = .002) levels were higher than those in the non‐AIG group. Endoscopic findings were similar between the two groups. Intestinal metaplasia was higher (P = .018) in the AIG group. None of the patients in the AIG group had H pylori infection (P = .004). One patient in the AIG group had enterochromaffin‐like cell hyperplasia.Conclusions: Our results show that, in children, H pylori infection may not play a role in AIG. AIG could be associated with vitamin B12 deficiency, iron deficiency, and APCA positivity in children. APCA and gastrin levels should be investigated for the early diagnosis of AIG and intestinal metaplasia.
- 26 June 2020
- Published by Wiley in Helicobacter
- Vol. 25 (5) , e12716
Open AccessAutoimmune atrophic gastritis: The role of Helicobacter pylori infection in children
Background: Autoimmune atrophic gastritis (AIG) is very rare in children. Despite a better understanding of histopathologic changes and serological markers in this disease, underlying etiopathogenic mechanisms and the effect of Helicobacter pylori (H pylori) infection are not well known. We aimed to investigate the relation between AIG and H pylori infection in children.Materials and Methods: We evaluated the presence of AIG and H pylori infection in fifty‐three patients with positive antiparietal cell antibody (APCA). Demographic data, clinical symptoms, laboratory and endoscopic findings, histopathology, and presence of H pylori were recorded.Results: The children were aged between 5 and 18 years, and 28 (52.8%) of them were male. Mean age was 14.7 ± 2.6 years (median: 15.3; min‐max: 5.2‐18), and 10 (18.8%) of them had AIG confirmed by histopathology. In the AIG group, the duration of vitamin B12 deficiency was longer (P = .022), hemoglobin levels were lower (P = .018), and APCA (P = .039) and gastrin (P = .002) levels were higher than those in the non‐AIG group. Endoscopic findings were similar between the two groups. Intestinal metaplasia was higher (P = .018) in the AIG group. None of the patients in the AIG group had H pylori infection (P = .004). One patient in the AIG group had enterochromaffin‐like cell hyperplasia.Conclusions: Our results show that, in children, H pylori infection may not play a role in AIG. AIG could be associated with vitamin B12 deficiency, iron deficiency, and APCA positivity in children. APCA and gastrin levels should be investigated for the early diagnosis of AIG and intestinal metaplasia.